Announcements Trials
Browse Landscape

Status

Recruiting 231Active not recruiting 109Not yet recruiting 57Completed 56Terminated 42Withdrawn 7Suspended 5Enrolling by invitation 2No longer available 1Available 1

Sponsor Class

INDUSTRY 1

Study Type

Expanded_access 1

Sponsor

Cancer Type

Breast 1

Conditions

Carcinoma, Non-Small-Cell Lung 4Multiple Myeloma 3Melanoma 3Lung Neoplasms 3Recurrence 2Prostatic Neoplasms 2Pancreatic Neoplasms 2Neuroblastoma 2Neoplasms 2Glioblastoma 2Wilms Tumor 1Uterine Neoplasms 1Urogenital Neoplasms 1Triple Negative Breast Neoplasms 1Thoracic Neoplasms 1Stomach Neoplasms 1Sarcoma, Ewing 1Rhabdomyosarcoma 1Rhabdoid Tumor 1Retinoblastoma 1Respiratory Tract Neoplasms 1Respiratory Tract Diseases 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Polycythemia Vera 1Pinealoma 1Ovarian Neoplasms 1Osteosarcoma 1Neuroectodermal Tumors, Primitive 1Neoplasms by Site 1Meningeal Neoplasms 1

Interventions

leronlimab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
No longer available × Triple Negative Breast Neoplasms × 1 year × Clear all
NCT04313075 2025-07-15

A Compassionate Use Study of Leronlimab in Breast Cancer

CytoDyn, Inc.

No longer available
Breast

Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡